[Heat shock protein protects beta cells. Is it possible soon to vaccinate against diabetes?].
D000280:Administration, Inhalation; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000628:therapy*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000628:therapy; D004311:Double-Blind Method; D006360:Heat-Shock Proteins / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D007515:Islets of Langerhans / Q000187:drug effects*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D014611:Vaccination
C473734:Exubera; D006360:Heat-Shock Proteins; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine